Podcasts about principal deputy director

Kathryn Turman served as the Assistant Director over the FBI Victim Services Division from 2002 – 2020. Former FBI Director Robert Mueller brought her to the FBI several months after the September 11th attacks with the mission to establish a robust, professional victim services program. In 2005, Ms. Turman established a terrorism and mass casualty Victim Services Response Team that has become an international model. Prior to joining the FBI, Ms. Turman served in the Department of Justice as Director of the Missing and Exploited Children's Program, Chief of the Victim Witness Assistance Unit in the United States Attorney's Office for the District of Columbia, and Principal Deputy Director and Director of the Office for Victims of Crime. Kathryn is arguably the Bureau's most consistently called-upon contributor. She presided over the FBI's victim-centered responses to every major case since 9/11, including the Boston Marathon bombings, multiple mass-casualty shootings, international kidnappings and murders, and scores of federal crimes. She retired from federal service in June 2020. Reality Life with Kate Casey What to Watch List: https://katecasey.substack.com Patreon: http://www.patreon.com/katecasey Like it to Know It: https://www.shopltk.com/explore/katecasey Twitter: https://twitter.com/katecasey Instagram: http://www.instagram.com/katecaseyca Tik Tok: http://www.tiktok.com/itskatecasey Facebook Group: https://www.facebook.com/groups/113157919338245See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Your first day at any new job is always a little stressful. But for Julia Petras, the day she started working at CDC was especially high stakes. In this episode of Contagious Conversations, we explore a mysterious outbreak that affected four patients in four months, sickened by a bacteria not seen before in North America. The FBI—and the public—wanted answers. We hear from CDC's Julia Petras, Dr. Jennifer McQuiston and Dr. Eric Pevzner about how the outbreak was solved by disease detectives in the Epidemic Intelligence Service.    Episode Quotes “There is no replacement for shoe-leather epidemiology. You can have all of your advanced biostatistics, your sophisticated software, but it doesn't replace the importance of talking to real people, to being physically there, doing some of that boots-on-the-ground detective work. There is no replacement for that.” — Julia Petras, Regional Epidemiologist, Global Influenza Branch, CDC “As a disease detective, you get to go and figure out how can you help protect people so that you can give people the opportunity to have healthy lives? And there's nothing more rewarding than getting to do that than as a disease detective at CDC.” — Dr. Eric Pevzner, CAPT, U.S. Public Health Service; Chief, Epidemiology and Laboratory Workforce Branch, Epidemic Intelligence Service, CDC “I remember I came in on a weekend to pick up some papers from my office and she and her EIS supervisor were holed up in a conference room with a big whiteboard, and they were trying to connect the dots and figure out where to go next and what questions needed to be answered, and they were always trying to pursue getting an answer for that case. And so the tenacity that was required to solve it was really impressive.” — Dr. Jennifer McQuiston, Principal Deputy Director, Division of High Consequence Pathogens and Pathology, CDC   To watch the original 1979 interview with Dr. Alexander Langmuir featured in this podcast, visit https://www.youtube.com/watch?v=NICfQM9d0CM   For more information and full episode transcripts, go to Contagious Conversations.

The Hon. Sue Gordon, President of Gordon Ventures, Member of the Defense Innovation Board, and former Principal Deputy Director of National Intelligence, and Sean Blackman, Co-founder and CEO of Nooks, return for part two of our unclassified discussion on the challenges new entrants face in the defense innovation ecosystem. They examine obstacles for small businesses, including allies and partners, such as navigating classification rules, the clearance application backlog, and streamlining compliance processes. Mr. Blackman shares how Nooks simplifies these steps for businesses, and Ms. Gordon discusses the need to modernize outdated policies and foster collaboration between government, industry, and academia to create an ecosystem that balances security, drives innovation, and attracts top talent. Nooks: https://nooks.works/ To receive updates about the conference please join our mailing list here: https://www.emergingtechnologiesinstitute.org/sign-up http://emergingtechnologiesinstitute.org https://www.facebook.com/EmergingTechETI https://www.linkedin.com/company/ndia-eti-emerging-technologies-institute https://www.twitter.com/EmergingTechETI

Trusted Workforce 2.0 is well underway, and as we await further progress on the National Background Investigations Bureau it's worth asking what's next in reform, and why this transformation matters. This special podcast with the Honorable Susan M. Gordon, former Principal Deputy Director of the Office of the Director of National Intelligence, and Andrew Razumovsky, Principal, CANDA Solutions centered on these crucial topics. Hosted on Acast. See acast.com/privacy for more information.

The Rich Zeoli Show- Full Episode (11/15/2024): 3:05pm- On Thursday, Donald Trump announced Robert F. Kennedy Jr. was his selection to serve as Secretary of Health and Human Services. Unsurprisingly, the far-left and members of the mainstream media have vociferously objected to his appointment. During a segment on CNN, host Jake Tapper stated: “Well, America, I hope you like measles.” 3:30pm- Tonight, former heavyweight champion of the world Mike Tyson fights social media influencer Jake Paul in a boxing match being streamed by Netflix. Matt has money on Paul. Justin has money on Tyson. But everyone is looking forward to this bizarre fight! 3:40pm- In his farewell address on January 17, 1961, President Dwight Eisenhower warned about public policy being captured by scientific and technological elites—focusing on initiatives that don't benefit Americans. 4:05pm- According to reports, Donald Trump's administration will offer White House press credentials to podcasters and social media accounts. 4:10pm- Bucks County Commissioners Vote to Count Illegal Ballots as Pennsylvania Senate Race Heads for Recount. Brittany Bernstein of National Review writes: “Bucks County, Pa., commissioners have voted to count ballots lacking proper signatures as the Pennsylvania Senate race heads to an automatic recount due to the razor-thin margin by which GOP Senator-elect Dave McCormick has beaten incumbent Senator Bob Casey. The 2-1 vote of the commissioners board violates a state Supreme Court ruling issued earlier this year and goes against the advice of the board's legal team, which advised against counting the 124 illegal ballots.” You can read the full article here: https://www.nationalreview.com/news/bucks-county-commissioners-vote-to-count-illegal-ballots-as-pennsylvania-senate-race-heads-for-recount/ 4:30pm- In a post to Truth Social, Donald Trump announced Doug Burgum's appointment to Secretary of the Interior. Burgum will also serve as Chairman of the newly formed National Energy Council. 4:45pm- While testifying before the House Select Subcommittee on the Coronavirus Pandemic, Principal Deputy Director of the NIH Dr. Lawrence Tabak, CDC Director of Office of Readiness and Response Dr. Henry Walke, and Chief Medical Officer of the FDA Dr. Hilary Marston conceded that mistakes were made by their agencies during the COVID-19 pandemic—resulting in a diminishment of public trust. 5:05pm- Dr. Wilfred Reilly—Professor of Political Science at Kentucky State University & Author of “Lies My Liberal Teacher Told Me”—joins The Rich Zeoli Show to discuss Robert Kennedy Jr.'s appointment to Secretary of Health and Human Services, Justice Neil Gorsuch defending Peanut the Squirrel, and JD Vance now following him on X! 5:35pm- Dr. Victoria Coates—Former Deputy National Security Advisor & the Vice President of the Davis Institute for National Security and Foreign Policy at The Heritage Foundation—joins The Rich Zeoli Show to react to Donald Trump's announced appointments, including Doug Burgum to Secretary of the Interior and Chairman of the newly formed National Energy Council. Dr. Coates is author of the upcoming book: “The Battle for the Jewish State: How Israel—and America—Can Win” which features a forward from Senator Ted Cruz. You can find the book here: https://a.co/d/iTMA4Vb 6:05pm- Host of The View Whoopi Goldberg said she was refused service at Holtermann's Bakery in New York—claiming it was because of her political beliefs. It turns out, Whoopi was lying. The bakery, which has been family owned for over 100-years, simply had an old boiler malfunction which prevented them from making baked goods. 6:10pm- From the floor of the House of Representatives Wiley Nickel (D-NC) openly advocated for the establishment of a Democrat-led “shadow government” working behind the scenes to undermine Donald Trump's policies/agenda. 6:15pm- While speaking with Bari Weiss of The Free Press, former CEO of PayPal Peter Thiel stated: “I don't thin ...

The Rich Zeoli Show- Hour 2: 4:05pm- According to reports, Donald Trump's administration will offer White House press credentials to podcasters and social media accounts. 4:10pm- Bucks County Commissioners Vote to Count Illegal Ballots as Pennsylvania Senate Race Heads for Recount. Brittany Bernstein of National Review writes: “Bucks County, Pa., commissioners have voted to count ballots lacking proper signatures as the Pennsylvania Senate race heads to an automatic recount due to the razor-thin margin by which GOP Senator-elect Dave McCormick has beaten incumbent Senator Bob Casey. The 2-1 vote of the commissioners board violates a state Supreme Court ruling issued earlier this year and goes against the advice of the board's legal team, which advised against counting the 124 illegal ballots.” You can read the full article here: https://www.nationalreview.com/news/bucks-county-commissioners-vote-to-count-illegal-ballots-as-pennsylvania-senate-race-heads-for-recount/ 4:30pm- In a post to Truth Social, Donald Trump announced Doug Burgum's appointment to Secretary of the Interior. Burgum will also serve as Chairman of the newly formed National Energy Council. 4:45pm- While testifying before the House Select Subcommittee on the Coronavirus Pandemic, Principal Deputy Director of the NIH Dr. Lawrence Tabak, CDC Director of Office of Readiness and Response Dr. Henry Walke, and Chief Medical Officer of the FDA Dr. Hilary Marston conceded that mistakes were made by their agencies during the COVID-19 pandemic—resulting in a diminishment of public trust.

Securing a place in the defense intelligence sector can be an uphill battle for small companies, universities, and other organizations aiming to participate in national security and intelligence-related projects. Today, we're exploring the unique challenges faced by these innovative players as they navigate stringent security requirements, costly infrastructure upgrades, and the complex world of classified projects. Unlike large defense contractors, these emerging entities often struggle with limited budgets and resources, hindering their ability to contribute groundbreaking ideas to national security. Our guests, the Hon. Sue Gordon, President of Gordon Ventures and former Principal Deputy Director of National Intelligence, and Sean Blackman, Co-founder and CEO of Nooks, offer insights into overcoming these obstacles and share the work currently being done to help small innovators bring their vision to the defense landscape. Nooks: https://nooks.works/ DIB Report: Lowering Barriers to Innovation: https://innovation.defense.gov/Portals/63/2_%2020240118%20DIB%20LBI%20Study.pdf To receive updates about the conference please join our mailing list here: https://www.emergingtechnologiesinstitute.org/sign-up http://emergingtechnologiesinstitute.org https://www.facebook.com/EmergingTechETI https://www.linkedin.com/company/ndia-eti-emerging-technologies-institute https://www.twitter.com/EmergingTechETI

Tommy checks in with Dr. Nirav Shah, Principal Deputy Director of the CDC

Special guest Alex J. Pollock, Senior Fellow with the Mises Institute and former Principal Deputy Director of the Office of Financial Research in the U.S. Treasury Department, joins us to discuss his recent blog post published on The Federalist Society website in which he urges Congress to look into the question of whether the Federal Reserve can lawfully continue to fund the CFPB if (as now) the Fed has no earnings. We begin with a review of the Supreme Court's recent decision in CFSA v. CFPB which held that the CFPB's funding mechanism does not violate the Appropriations Clause of the U.S. Constitution. Alex follows with an explanation of the CFPB's statutory funding mechanism as established by the Dodd-Frank Act, which provides that the CFPB is to be funded from the Federal Reserve System's earnings. Then Alex discusses the Fed's recent financial statements and their use of non-standard accounting, the source of the Fed's losses, whether Congress when writing Dodd-Frank considered the impact of Fed losses on the CFPB's funding, and how the Fed can return to profitability. We conclude the episode by responding to arguments made by observers as to why the Fed's current losses do not prevent its continued funding of the CFPB, potential remedies if the CFPB has been unlawfully funded by the Fed, and the bill introduced in Congress to clarify the statutory language regarding the CFPB's funding. Alan Kaplinsky, Senior Counsel in Ballard Spahr's Consumer Financial Services Group, hosts the conversation.

The Office of Policy advises and supports priorities of the Secretary of Energy and other departmental elements on a range of topics related to domestic energy and climate policy issues, including technology policy, deployment and infrastructure policy, state, local, tribal, and territorial policy, and energy jobs.  The Office of Policy works collaboratively across the department and federal government, leveraging existing capabilities of program offices and national labs to achieve policy analysis objectives and build long-term analytical capabilities. Carla Frisch is the Acting Executive Director and Principal Deputy Director of the U.S. Department of Energy (DOE) Office of Policy. The Office of Policy provides analysis on all aspects of the energy sector and works across government to enable policy in support of a clean energy economy. Frisch has directed DOE offices focused on climate and environment, energy efficiency, renewable energy, transportation, and electricity systems. She has worked extensively on energy system vulnerabilities and solutions. Previously, she led the U.S. Program at RMI and was an Adjunct Professor at Northwestern University. Frisch holds degrees from Duke University and UNC Chapel Hill. Show Notes: [2:49] - We are currently in a historic moment for energy policy, climate policy, and the American economy. [4:13] - Since 2021, we have seen over 400 new or expanded manufacturing facilities in the US. Carla shares some data and goals for upcoming years. [5:40] - This is the result of a concerted industrial strategy with four pillars. [7:54] - Carla explains the DOE's role, specifically the Office of Policy, regarding the Inflation Reduction Act. [11:09] - We're seeing a major shift and impact in the US, saving Americans money on their utility bills and reducing US greenhouse gas emissions. [13:40] - We are also experiencing a historic moment when it comes to this tax credit. [16:46] - There is a tax credit for an energy audit for those who don't know where to start. [18:54] - What job and career opportunities are there at the DOE? [20:45] - Carla shares what inspired her to commit to climate policy and the advice she has for those looking to do that same. Links and Resources: Energy.gov

The Rich Zeoli Show- Full Episode (05/17/2024): 3:05pm- Rich opens the show on a somber note—friend, and frequent listener, Sid Weiss passed away earlier this week. 3:30pm- While appearing before the House Select Subcommittee on the Weaponization of the Federal Government on Wednesday, Michael Cohen's former attorney Robert Costello accused Cohen of lying during the Donald Trump “hush money” trial. Costello said that Cohen once told him: “I swear to God, Bob, I don't have anything on Donald Trump…I don't have anything on Donald Trump.” You can read more here: https://www.washingtonexaminer.com/news/justice/3004761/michael-cohen-lawyer-accuses-lying-trump-trial/ 3:40pm- Reacting to Michael Cohen's testimony in the Donald Trump “hush money” trial on Thursday, CNN legal analyst Elie Honig said Cohen had his “knees chopped out” from under him during cross-examination. 4:05pm- On Thursday, President Joe Biden asserted executive privilege—preventing the House of Representatives from acquiring audio recordings of an interview the president conducted with Department of Justice Special Counsel Robert Hur. In a letter to House Oversight Committee Chairman James Comer (R-KY), White House counsel Edward Siskel reasoned: “The absence of a legitimate need for the audio recordings lays bare your likely goal—to chop them up, distort them and use them for partisan political purposes.” 4:15pm- The Wall Street Journal Editorial Board writes of President Joe Biden's assertion of executive privilege: “The privilege claim is bogus on two grounds. First, once a President waives a privilege right, it can't be reclaimed. Mr. Biden conceded that the interview wasn't privileged, and there's no legal basis to say that a recording is different from a transcript. Even if Mr. Biden had first claimed privilege over the interview, that wouldn't pass legal muster because the interview subject didn't concern his presidential duties or White House deliberations. It concerned his handling of documents while in the Senate, as Vice President, or as a private citizen. Mr. Siskel's claim that the goal is to protect the Justice Department's ‘law enforcement investigations' also doesn't work. Such a claim of law-enforcement privilege typically attends to a continuing investigation, but Mr. Hur's work is complete. He has filed his report and closed up shop.” You can read the full editorial here: https://www.wsj.com/articles/joe-biden-executive-privilege-recordings-robert-hur-interview-edward-siskel-265ab86b?mod=opinion_lead_pos2 4:40pm- A Thursday House of Representative Subcommittee hearing devolved into total chaos when Republican Marjorie Taylor Green exchanged insults with Democrats Alexandria Ocasio Cortez and Jasmine Crockett. No wonder nothing ever gets done in Congress! But at least it was entertaining. 5:05pm- Dr. Wilfred Reilly—Professor of Political Science at Kentucky State University and author of “Lies My Liberal Teacher Told Me”—joins The Rich Zeoli Show to discuss the hilarious Congressional feud over “bleached hair” and “fake eyelashes.” Marjorie Taylor Green, Alexandria Ocasio Cortez, and Jasmine Crockett gave us a Congressional fight we won't soon forget—no matter how hard we try. PLUS, Dame Judi Dench takes a stand against “trigger warnings.” Dr. Reilly's new book releases on June 11th but you can pre-order it now: https://a.co/d/jd6PjBb. 5:30pm- Jimmy Failla—stand-up comedian & Fox News host—joins The Rich Zeoli Show to discuss his parody song being “reposted” by President Donald Trump on Truth Social, his recent visit to the White House, and his dream of driving the president's limousine: “The Beast.” Failla hosts “Fox News Saturday with Jimmy Failla”—and this week, Rich will be on the panel! Failla also has an upcoming comedy show in Red Bank, New Jersey on June 22nd and promises that if the Zeoli Army buys 100 tickets, he will attend The Rich Zeoli Show's live broadcast from Cape May on June 21st. So, buy tickets! https://www.ticketmaster.com/event/1D00606EC69C218F 6:05pm- While being questioned by Rep. Debbie Lesko (R-AZ) during a recent House Select Subcommittee hearing on the coronavirus pandemic, former Principal Deputy Director of the National Institutes of Health (NIH) Dr. Lawrence Tabak confirmed that the NIH did fund “gain-of-function research at the Wuhan Institute of Virology through EcoHealth.”   6:30pm- Tudor Dixon—Former Republican Nominee for Governor of Michigan & host of The Tudor Dixon Podcast—joins The Rich Zeoli Show to discuss the current state of the 2024 presidential election. 6:40pm- Reacting to news that President Joe Biden and former President Donald Trump agreed to a debate scheduled for June 27th, Congresswoman Nancy Pelosi (D-CA) said she would “would never recommend” debating Trump.

The Rich Zeoli Show- Hour 4: 6:05pm- While being questioned by Rep. Debbie Lesko (R-AZ) during a recent House Select Subcommittee hearing on the coronavirus pandemic, former Principal Deputy Director of the National Institutes of Health (NIH) Dr. Lawrence Tabak confirmed that the NIH did fund “gain-of-function research at the Wuhan Institute of Virology through EcoHealth.”   6:30pm- Tudor Dixon—Former Republican Nominee for Governor of Michigan & host of The Tudor Dixon Podcast—joins The Rich Zeoli Show to discuss the current state of the 2024 presidential election. 6:40pm- Reacting to news that President Joe Biden and former President Donald Trump agreed to a debate scheduled for June 27th, Congresswoman Nancy Pelosi (D-CA) said she would “would never recommend” debating Trump.

Michael Hayden is a retired United States Air Force four-star general and former Director of the National Security Agency, Principal Deputy Director of National Intelligence, and Director of the Central Intelligence Agency. He joins the podcast to discuss his book: "The Assault on Intelligence: American National Security in an Age of Lies." Original air date 16 May 2018. The book was published 01 May 2018.

Sasha Chavkin, Senior Reporter for The Examination, tells us about his investigation into whether the food industry is misusing anti-diet messages; Dr. Timothy Harrison, Principal Deputy Director in the Office of Infectious Disease and HIV AIDS Policy with the U.S. Department of Health and Human Services, says syphilis and congenital syphilis are the focus of a new federal task force; and an ASTHO blog article explains how leadership by example can benefit employees. The Washington Post News Article: As obesity rises, Big Food and dietitians push ‘anti-diet' advice ASTHO Report: Policy Considerations for Reducing Congenital Syphilis CDC Webpage: STI Awareness Week U.S. Department of Health and Human Services Webpage: HHS Announces Department Actions to Slow Surging Syphilis Epidemic ASTHO Blog Article: Leading by Example Benefits Employees ASTHO Webpage: Stay Informed  

In this episode, Michael V. Hayden, General USAF (Ret), Former Director of NSA and CIA, and first Principal Deputy Director of National Intelligence (PDDNI), discusses the biggest challenges he faced in the senior positions he held in the U.S. Intelligence Community. He also offers advice to those considering careers in intelligence. Recorded 31 July 2023. Interviewer: Jim Hughes, AFIO President and former CIA Operations Officer. 

What good does it do to start a big research project? How do you get it to soar? Dr. Anna Barker has some answers about that from the past, the present and the future. She is chief strategy officer at the Ellison Institute, a think tank and research institute. Before that, she was the principal deputy director of the US National Cancer Institute and deputy director for strategic scientific initiatives there. One of her projects is The Cancer Genome Atlas, co-directed with Dr. Francis Collins. This episode will be about cancer. Cancer is upsetting, of course, but this episode might feel empowering. The podcast is also about academia, physics, information theory, big data, history and science policy. (Art: J. Jackson. Music: Michael Drake - Solstice licensed from artlist.io) 

As investors around the world are racing to ride the next AI unicorn, leading Silicon Valley firm General Catalyst led the creation of the partnership between venture capital firms and Sec. Gina Raimondo and the Commerce Department to develop responsible AI guidelines for themselves and their portfolio companies. Paul Kwan and Teresa Carlson of General Catalyst walk us through their new investment thesis on building global resilience and their focus on responsible innovation and radical collaboration. In the second panel, we'll hear from former NSA deputy director George Barnes of Red Cell Partners, Saildrone's former Head of Defense, Cameron McCord and Anduril's chief revenue officer Matt Steckman on how portfolio companies are using responsible AI to drive growth and innovation in defense, intelligence, and national security with comments by Sue Gordon, former Principal Deputy Director of National Intelligence.

Join our host Hadeil Ali for this week's episode on national intelligence with the Honorable Susan M. Gordon, former Principal Deputy Director of National Intelligence.  The pair discussed how a zoology degree led to a decades-long career at the CIA, her shock resignation in 2019, and why she thinks women can have it all. 

Welcome to a special episode of the State Secrets podcast. Cipher Brief CEO & Publisher Suzanne Kelly recently welcomed the Director of CIA's Open Source Enterprise Randy Nixon, to the virtual studio for a special briefing to talk how CIA uses OSINT (Open Source Intelligence) in its daily analytic tradecraft. He also talked about  a new tool CIA just launched to help IC analysts better navigate the vast amounts of open source information flowing in each day. Listen in to the briefing, which drew fascinating questions from former Principal Deputy Director of National Intelligence The Hon. Susan Gordon, former Deputy Director of Analysis for CIA, Linda Weissgold, and chief product officer at Janes, Ben Conklin. 

In this compelling episode of "The Rational Egoist," host Michael Leibowitz sits down with Alex J. Pollock, a senior fellow at The Mises Institute and former Principal Deputy Director of the Office of Financial Research in the U.S. Treasury Dept. Together, they delve into the fascinating yet fraught world of the Federal Reserve, an institution often misconceived as a central economic manager. The Federal Reserve, in its simplest form, comprises 12 regional banks attempting to regulate the U.S. economy. Its original mandate was to inject liquidity into the financial system during times of crisis. However, as Michael and Alex point out, the persistent and unrestrained expansion of money supply even after crises have been resolved has converted this mechanism into an ongoing problem, rather than a solution. The conversation takes a historical turn when they discuss the U.S. government's suppression of the gold standard and its unilateral ban on citizens owning gold. Remarkably, while American civilians were barred from gold ownership, the U.S. government continued to accumulate large reserves of gold by purchasing it overseas.But the real kicker comes when our experts examine the ramifications of divorcing the U.S. dollar from gold in 1971. This shift has led to a monetary system with virtually no constraints on the amount of currency that can be printed, setting the stage for escalating inflation and subsequently, complex political challenges. Despite its numerous failings, the power of the Federal Reserve continues to grow, becoming increasingly centralised. The paradox is as disconcerting as it is true: the more mistakes the Federal Reserve makes, the more potent it becomes. Join Michael and Alex as they unravel these complicated threads, offering keen insights into an institution whose influence stretches far and wide but whose true impact remains poorly understood. This episode is not just an analysis but a cautionary tale, highlighting the perils of placing too much power in the hands of a single entity. Michael Leibowitz is a renowned philosopher, political activist, and the esteemed host of the Rational Egoist podcast. Inspired by the philosophical teachings of Ayn Rand, Leibowitz passionately champions the principles of reason, rational self-interest, and individualism, seeking to empower others through his compelling work. His unwavering commitment to these ideals has garnered him a dedicated following of like-minded individuals.Leibowitz is a versatile author, co-authoring the thought-provoking book titled "Down the Rabbit Hole: How the Culture of Correction Encourages Crime." This groundbreaking work delves into societal attitudes surrounding punishment and rehabilitation, shedding light on how misguided approaches have contributed to the rise of crime and recidivism. Additionally, he has authored the book "View from a Cage: From Convict to Crusader for Liberty," offering an intimate portrayal of his personal journey while exploring the philosophies that influenced his transformation.As you embark on your intellectual journey, join Michael Leibowitz as he advocates for reason, individualism, and the pursuit of self-interest, inspiring others to embrace a philosophy that empowers and uplifts the human spirit. For a deeper exploration of his ideas and insights, don't miss the opportunity to read "Down the Rabbit Hole: How the Culture of Correction Encourages Crime," co-authored by Michael Leibowitz. And also, delve into his book "View from a Cage: From Convict to Crusader for Liberty." Both books are available for purchase using the following links: "Down the Rabbit Hole": https://www.amazon.com.au/Down-Rabbit-Hole-Corrections-Encourages/dp/197448064X "View from a Cage": https://books2read.com/u/4jN6xj

#USA:  Patrick Daly: Pat Daly is the Principal Deputy Director/COO of SCN, the Secure Community Network.  Malcolm Hoenlein. https://www.timesofisrael.com/2-more-us-synagogues-targeted-by-fake-bomb-threats-ahead-of-high-holidays/ 1900 Jerusalem

This is Part 1 of my Reasonably Spontaneous Conversation with Sue Gordon. Sue was the fifth Principal Deputy Director of National Intelligence at the Office of the Director of National Intelligence (DNI) from August 2017 to August 2019. As PDDNI, Sue was a key advisor to the President and National Security Council and led the 17-member Intelligence Community. With more than three decades of experience in the IC, Sue has served in a variety of leadership roles spanning numerous intelligence organizations and disciplines. Prior to the DNI, Sue served as the Deputy Director of the National Geospatial-Intelligence Agency from 2015 to 2017, helping the director lead the agency and manage the National System of Geospatial Intelligence. Before joining the NGA, she served for 27 years at the Central Intelligence Agency, rising to senior executive positions in each of the Agency's four directorates: operations, analysis, science and technology, and support. In 1998, she designed and drove the formation of In-Q-Tel, a private, non-profit company whose primary purpose is to deliver innovative technology solutions for the agency and the IC. She is the recipient of numerous government and industry awards, including the Distinguished Intelligence Medal and the Distinguished Presidential Rank Award. Sue earned a Bachelor of Science from Duke University. A trusted authority on strategy, innovation and leadership, Sue is currently a consultant on global risk, technology, cyber and space issues and a member of the Board at Pallas Advisors, a Washington D.C.-based consultancy --- Support this podcast: https://podcasters.spotify.com/pod/show/dennis-tardan/support

Sue Gordon is the former Principal Deputy Director of National Intelligence. She had a 30+ year career with the CIA, as well as serving as Deputy Director of the National Geospatial-Intelligence Agency. Auren and Sue discuss shifting global power dynamics and the nature of modern intelligence in an ever-evolving world. They delve into the realm of cyber defense and Sue gives an overview of the expanding threat landscape that stretches far beyond government borders. They also discuss open source intelligence (OSINT) and the cutting-edge world of satellite technology and geospatial intelligence.Sue and Auren also explore the dynamics of coalitions and how they've challenged established perceptions about military invasions and global power dynamics in the wake of the Ukraine invasion. They also discuss the inner workings of INQTEL, the CIA's technology investment arm, and get a firsthand account of Sue Gordon's extensive experience at the helm of various CIA departments.World of DaaS is brought to you by SafeGraph & Flex Capital. For more episodes, visit safegraph.com/podcasts. You can find Auren Hoffman on Twitter at @auren and Sue Gordon on LinkedIn.

Sue Gordon served in the CIA for 20 years, and was the Principal Deputy Director of National Intelligence under President Trump. She resigned from that position, citing “patriotism” as her one of her reasons. She is now speaking out against the former president, and highlighting the risks he poses to America's security.     Subscribe to the Against All Enemies podcast here: https://podcasts.apple.com/us/podcast/against-all-enemies/id1696526687   Support our sponsor, Storied Hats, here: www.storiedhats.com, and use code BOATS at checkout for 15% off the first hat, 50% off the second.   Credits: Producer and Co-Host, Ken Harbaugh Producer, Mikel Ellcessor Associate Producer, Isabel Robertson Theme music by Stephanie Kowal & Seowon Hyun Theme music produced by Tony Morales Motion Designer, Joe Vaccarino

Sue Gordon, former Principal Deputy Director of National Intelligence, joins host Ken Harbaugh to talk about national security, cybersecurity threats, and what intelligence information holds the most value. Sue served as Principal Deputy Director of National Intelligence and Deputy Director of the National Geospatial Intelligence Agency after having spent more than two decades at the CIA. She is currently an advisor to a number of organizations in the national defense and security space, including CACI International, with a special focus on information security.

Bethany Alcauter, Director of Research and Public Health Programs at the National Center for Farm Worker Health, is focused on local action when it comes to rural health infrastructure; an ASTHO online briefing discussed the coming RSV season; and this episode marks the second anniversary of the ASTHO newscast and features the first newscast interview with Dr. Nirav Shah, Principal Deputy Director of the CDC.   National Agricultural Worker Health Program: Combating Covid-19

In a special episode, Dr Miah Hammond-Errey is joined by Michael Green, CEO of the United States Studies Centre, to consider the conversations and developments around technology decoupling between the United States and China across the past six months. Drawing on insights from previous guests on the podcast, Miah and Mike cover topics from international standards, subsea cables and individual user trust in technology to the role of Japan and Australia. They also discuss the role of alliances, digital infrastructure, national security and historical lessons that can inform this evolving area of debate.Technology and Security is hosted by Dr Miah Hammond-Errey, the inaugural director of the Emerging Technology program at the United States Studies Centre, based at the University of Sydney. Clips used in this recording:Jessica Hunter, First Assistant Director-General Access & Effects Operations at the Australian Signals Directorate, recorded in Canberra, February 2023 for Technology and Security Episode 1.Alex Lynch, Google Australia Public Policy Manager, recorded in Sydney, March 2023 for Technology and Security Episode 2.Julie Inman Grant, Australia's eSafety Commissioner, recorded in Sydney, March 2023 for Technology and Security Episode 3.Dr Robert Atkinson, President and Founder of the Information Technology and Innovation Foundation, recorded in Sydney in March 2023 while at the USSC as a Visiting Fellow.The Hon Dr Andrew Leigh MP, Assistant Minister for Competition, Charities and Treasury and Assistant Minister for Employment, and Dr Robert Atkinson, President and Founder of the Information Technology and Innovation Foundation, recorded in Canberra, March 2023 at the USSC's ‘Technology, Innovation And Strategic Competition' event.Sue Gordon, former Principal Deputy Director of National Intelligence at the Office of the Director of National Intelligence, recorded in Washington, May 2023 for Technology and Security Episode 4.Resources mentioned in the recording:  (USSC Polling Explainer) Collaboration with trusted allies and distrust in Chinese technology: American, Australian and Japanese views on technology (Standards Australia Report) Iconic Nation(ASD Resources) Protecting your devices and cybersecurity(USSC Report) Secrecy, sovereignty and sharing: How data and emerging technologies are transforming intelligence (Elisabeth Braw, Foreign Policy article on subsea cables) Decoupling Is Already Happening – Under the Sea (White House) CHIPS and Science Act (US Bureau of Industry and Security) Commerce Implements New Export Controls on Advanced Computing and Semiconductor Manufacturing Items to the People's Republic of China (PRC)(Australian Defence Force) Defence Strategic Review 2023(White House) National Security Strategy(Ministry of Foreign Affairs of Japan) National Security Strategy (Wall Street Journal) Potato Chips Vs. Computer Chips – High Technology Any Way You Slice ItMaking great content requires fabulous teams. Thanks to the great talents of the following. Special co-host: Dr Mike GreenResearch support and assistance: Tom BarrettProduction: Elliott BrennanPodcast Design: Susan BealeMusic: Dr Paul MacThis podcast was recorded on the lands of the Gadigal people, and we pay our respects to their Elders past, present and emerging — here and wherever you're listening. We acknowledge their continuing connection to land, sea and community, and extend that respect to all Aboriginal and Torres Strait Islander people. 

Today, on Breaking Barriers: Understanding the AI Revolution, Morgan Viña speaks with Sue Gordon, the former Principal Deputy Director of National Intelligence. In this episode, Morgan and Ms. Gordon help break down how AI impacts U.S. interests and the current capabilities of AI in the defense sector.What does the future of the IC and the defense sector look like with the emergence of AI? What defense capabilities are enhanced by the incorporation of AI? How is artificial intelligence impacting U.S. relationships with both allies and adversaries? Tune into Fault Lines all summer to hear from more AI experts as part of, Breaking Barriers: Understanding the AI Revolution!Want to learn more about this topic? https://www.defense.gov/Spotlights/Artificial-Intelligence/Follow our experts on Twitter:@morganlroachLike what we're doing here? Be sure to rate, review, and subscribe.And don't forget to follow @masonnatsec on Twitter! Hosted on Acast. See acast.com/privacy for more information.

Dr Miah Hammond-Errey interviews Susan Gordon, former US Principal Deputy Director of National Intelligence, discussing the potential of public disclosures of intelligence to build trust, the nuanced differences between American and Australian cultures that impact technology policy and innovation, especially in areas like AI regulation, and what is needed to make AUKUS Pillar II a success. They also cover the increasing role of private-sector firms in national security — from supply chain decisions to the role of Starlink in the Russian invasion of Ukraine to Chinese infrastructure investment in the Indo-Pacific — how best to harness them and their technologies, and the new heights disinformation could reach, and the fact “2022 was the last time we talked about AI in the future.”Susan M. Gordon was the former Principal Deputy Director of National Intelligence, advising the President on intelligence matters and providing operational leadership of the US intelligence community. She has had an extensive career in the US Intelligence Community — working as the Deputy Director of the National Geospatial-Intelligence Agency (NGA) and spending 29 years at the CIA where she also led the establishment of In-Q-Tel, the CIA's venture arm. She is a fellow at Duke and Harvard Universities and has worked with leading companies and government on intelligence integration, outreach and driving innovation.Technology and Security is hosted by Dr Miah Hammond-Errey, the inaugural director of the Emerging Technology program at the United States Studies Centre, based at the University of Sydney.Miah's Twitter: https://twitter.com/Miah_HEThe USSC website: https://www.ussc.edu.au/Resources mentioned in the recording:  (USSC Report) Secrecy, sovereignty and sharing: How data and emerging technologies are transforming intelligence (USSC Polling Explainer) Collaboration with trusted allies and distrust in Chinese technology: American, Australian and Japanese views on technology(USSC Disinformation Commentary) Dealing with disinformation: A critical new mission area for AUSMIN Making great content requires fabulous teams. Thanks to the great talents of the following.  Research support and assistance: Tom Barrett  Production: Elliott Brennan  Podcast design: Susan Beale Music: Dr Paul Mac This podcast was recorded in Washington DC, which sits on the ancestral lands of the Anacostans or Nacotchtank, and the neighbouring Piscataway and Pamunkey peoples. We acknowledge the Native Peoples on whose ancestral homelands we gather and pay our respects to their elders past and present — here and wherever you're listening.

0:00 - Mayor Lightfoot sat down with ABC 7's Craig Wall, blames "anger bubble" for election loss   10:51 - Dan & Amy take listener reaction to Lightfoot's interview with Craig Wall   30:57 - Dan & Amy report on the AP Calculus class at Evanston Township H.S. "...the course is restricted to students who identify as Black, all genders." "...the course is restricted to students who identify as Latinx, all genders." Neo-segregation is the absurdity of identitarianism taken to its logical end.   49:36 - Professor of economics and finance at the University of Michigan, Carpe Diem blogger for the American Enterprise Institute & Title IX watch dog, Mark Perry, shares the federal civil rights complaint he filed with the Chicago Office for Civil Rights against ETHS for their AP Calculus class   01:04:22 - Senior Research Fellow for Defense Programs at The Heritage Foundation, Dakota Wood, on the unraveling of Epstein and the Ukraine offensive    01:19:03 - Highlights from the WHCA Dinner   01:23:18 - Senior Fellow with the Mises Institute, served as the Principal Deputy Director of the Office of Financial Research in the U.S. Treasury Department and former President and CEO, Federal Home Loan Bank of Chicago, Alex Pollock, on the duping of Jerome Powell and the Fed absolving itself from the Silicon Valley Bank. Check out Alex' most recent book Surprised Again!―The COVID Crisis and the New Market Bubble   01:39:23 - The New face of Hate: Liam Morrison of Middleborough, MS   01:59:56 - Dan & Amy react to Lori Lightfoot's letter to TX Gov Abbott   See omnystudio.com/listener for privacy information.

Auburn University's McCrary Institute, FDD, and CSC 2.0, hosted a virtual event on the cyber risks in space. The event features former Chair of the House Permanent Select Committee on Intelligence Mike Rogers; former Principal Deputy Director of National Intelligence Sue Gordon; Skycorp CEO Lt. Gen. (Ret.) Steven L. Kwast; CSC 2.0 Executive Director and Senior Director of FDD's Center on Cyber and Technology Innovation RADM (Ret.) Mark Montgomery. Moderated by McCrary Institute's Frank Cilluffo, the conversation discusses the best path forward in addressing cybersecurity challenges unique to space systems, cybersecurity as a tool to support new and emerging space-based missions, and ways to enhance the public-private partnership model with genuinely shared risk management responsibilities.

It looks like the bill is finally coming due after decades of reckless monetary policy and out of control federal spending. After 40 years of relatively stable prices, we now have raging inflation. Interest rates have risen dramatically. Mortgage rates have more than doubled. And commercial banks are now sitting on more than $600 billion of unrealized bond losses.  Of course, and as expected, with the Silicon Valley Bank bailout, the Regulators have pulled out their default playbook declaring yet another institution systematically risky, taking another step toward the federalization of our banking system.  But there's also something new to worry about: regulatory mission drift. The Fed's historical mandates are to 1) promote price stability and 2) full employment and a safe and sound banking system. But instead, the Fed - and the Treasury - have changed their priorities to promote the progressive policies of climate change and equity.  Joining me to talk all this through are Alex Pollock and Steve Dewey. Both are grizzled veterans of the banking and regulatory world, which, as Alex points out, has been hit by a major crisis every decade since the 1970s. Together we have many decades of experience in financial markets. Alex and I have been conversing with each other, and interrupting each other, for almost fifty years.   Alex is a Senior Fellow at the Mises Institute and was Principal Deputy Director of the Office of Financial Research of the U.S. Treasury Department in 2019 and through 2021. He was also my second boss in the commercial banking world almost 45 years ago and was on my board at Allied Capital Corporation as we worked through the 2008 crisis and its aftermath.  Steve Dewey worked for several years in Asia during the Asian financial crisis and for the FDIC during and after the 2008 financial crisis where he was involved in the resolution of failed banks.  According to Alex, “We are still living in the aftermath of the long manipulation of interest rates and financial markets by the Federal Reserve and the club of central banks worldwide: the vast expansion of money and suppression of interest rates to an abnormally low level. Now we're seeing the results.”   Meantime, rather than being the above-the-fray dispassionate wise actor, the Federal Reserve has become part of the problem:  Just in the last six months, the Fed itself lost $44 billion which exceeds its capital of $42 billion. A big portion of its $8.7 trillion in assets are highly vulnerable to rising interest rates. Ironically, the Fed's interest rate risk is similar to SVB's.  So, what's going to happen next? The Fed and the Treasury seem likely to take more control in the name of risk management. The banking system holds $17 trillion of deposits and Treasury Secretary Janet Yellen recently declared that these would be de facto insured by the Treasury, the Fed and the FDIC.   But consider this: the FDIC's deposit insurance fund is $128 billion, which is - putting it mildly - a little short of $17 trillion. Also, if the Fed continues losing money on its mortgage-backed securities, it will be losing over $100 billion a year.    Republican Senator Everett Dirksen, the Minority leader during the 1960s Kennedy-Johnson years, once said “a billion here, a billion there, and pretty soon we're talking real money.” Now we're talking trillions. Has the banking system become to big to save? Will the “solution” be a nationalized bank and a digital currency to prevent a collapse of the system? Or something else? How do the woke climate and equity agendas figure into this?  There's a lot to speculate about here. Join in our conversation for our take on the crisis.  As always, we try to make complicated things easier to understand and nothing right now seems more complicated than our money.

In this week's State Secrets Podcast, Host Suzanne Kelly talks with The Hon. Susan M. Gordon, a career Intelligence Officer, former Principal Deputy Director of National Intelligence and current member of the Defense Innovation Board, about Balloons, China, Ukraine, Russia and the new world order as well as the role that AI plays in all of it.

Neil Wiley has lead some of the US Intelligence Community's most important analytical functions. His career in intelligence began as a Naval Intelligence Officer in an operational intelligence center focused on support to critical operational naval missions. He would later serve joint intelligence missions in Europe, would rise to lead all analytical activities at the Defense Intelligence Agency and in DoD Combatant Commands, and would later serve as the Chairman of the famed National Intelligence Council (NIC). Also served as a senior leader at ODNI, including leading the entire intelligence community as the Principal Deputy Director of National Intelligence from May 13, 2020 until February 2021. In this OODAcast we learn some of what made Neil tick, diving into his education, his early career intent, the role of serendipity in helping him transition to the intelligence community, and his approach to leadership and management. We also dive into big issues of optimizing intelligence including ways organizations can help guard against cognitive bias. Neil provides insights into his approaches to: – Training analytical methods and understanding which methods should be applied to which situations – Ways to teach analysts to spot their own cognitive bias and seek to mitigate, and ways to use the benefits of teams to help spot and mitigate analytical flaws – Ways to avoid deception by adversaries – Methods that can improve mental models – The mission of the National Intelligence Council and its key products, including those available to the public – Ways to find balance between the need to serve policy makers and military leaders without being captured by and influenced in appropriately by them – The role of the ODNI, what it is and what it should be – The thesis that the US is about to enter and age of abundance and what this means for the US and the world – What CEOs need to know about geopolitical risk

Chrissie Juliano, Executive Director of the Big Cities Health Coalition, says the Community Safety Campaign is about making sure people who live in communities have livable wages, and affordable and safe housing; Carolyn McCoy, ASTHO's Senior Director of Federal Government Affairs, shares how ASTHO is keeping a close eye on changes in leadership on committees that direct public health policy and funding; ASTHO's Immediate Past President Dr. Nirav Shah will attend the President's State of the Union address tonight in Washington D.C. as he gets ready to become the Principal Deputy Director at the CDC; and ASTHO's latest Insight and Inspiration event is coming up on Wednesday, February 22nd. Big Cities Health Coalition Webpage:  Community Safety Campaign Local Today News Article: Dr. Shah is attending State of the Union as he prepares for his new federal role ASTHO Webpage: Insight and Inspiration: Conversations for Public Health Leaders

0:00 - Dan & Amy react to yesterday's NFL playoff results   9:37 - Police bodycam video of Paul Pelosi's attack. Anybody still think these two are lovers?   20:21 - Kara Lynne: fired from gaming company for social media follows 26:23 - Dan & Amy offer reaction to the Tyre Nichols videos   01:06:20 - Vice President of the Kathryn and Shelby Cullom Davis Institute for International Studies at The Heritage Foundation, Lt Col James Carafano, weighs in on Ukraine/Russia and Durham Report/FBI. For more from Jim @JJCarafano   01:26:27 - Beauty & The Bingo in Princeton, TX   01:38:16 - DuPage County Sheriff, James Mendrick, shares his thoughts on the Memphis Police and explains why he isn't enforcing Pritzker's weapons ban 01:57:53 - Senior Fellow with the Mises Institute, served as the Principal Deputy Director of the Office of Financial Research in the U.S. Treasury Department and former President and CEO, Federal Home Loan Bank of Chicago, Alex Pollock:  How to pay all of the Treasury's bills without raising the debt limit. You can also check out Alex's book Finance and Philosophy—Why We're Always SurprisedSee omnystudio.com/listener for privacy information.

Vaccine development is a tremendous scientific breakthrough. In Part Two of this ASCO Education Podcast episode, Dr. Doug Lowy, Principal Deputy Director of the National Cancer Institute describes overcoming the hesitancy of taking vaccines in the era of Covid (:57), the scientific impacts of other nations like China (3:54), the importance and the standing of the NCI (5:10) and the future of oncology (10:36). If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at education@asco.org. TRANSCRIPT Pat Loehrer: Hi, I'm Pat Loehrer, Director of Global Oncology and Health Equity, at Indiana University. I'm here with Dave Johnson, a colleague and friend, and Medical Oncologist at the University of Texas Southwestern in Dallas, Texas. This is the second half of our Oncology, Etc., conversation with Principal Deputy Director of the NCI, and Chief of the Intramural Laboratory of Cellular Oncology in the Center for Cancer Research, Dr. Doug Lowy. In part one, we chatted with Dr. Lowy about his interest in cancer, which was developed through his personal academic experiences, including that of his parents, as well as his groundbreaking work on the HPV vaccine with Dr. John Schiller. Today, we're going to continue our conversation with Dr. Lowy by asking him about overcoming the hesitancy of taking vaccines in the era of COVID.   Dr. Doug Lowy: Pat, it's very difficult. There was some vaccine hesitancy when the HPV vaccine was introduced initially. My view is that the people you want to speak to and with, are the people whose minds can be changed. So, I don't try to change the minds of people who are opposed to vaccination for one reason or another, but instead, try to talk with people about evidence, but directing it towards those people whose minds potentially can be changed. A big advantage with the HPV vaccine is that this has been going on over a number of years. With COVID, everything happened in a greatly truncated way. So, the vaccine was introduced less than a year after the pandemic. But concomitant with that was a lot of vaccine hesitancy, and I think that that's going to be difficult to overcome. What I have really worried about is whether the vaccine hesitancy associated with COVID might extend to other vaccines and not just to the HPV vaccine, but to childhood vaccines, et cetera. The national data for 2020 and 2021 for HPV vaccination is almost counterintuitive and provisionally reassuring, both. Compared to 2019, the last full year without the pandemic, the number of people being vaccinated with the HPV vaccine went up between '19 and '20, and between '20 and '21, went up again. So, at least by that metric and through that time, it doesn't look as though the vaccine hesitancy associated with Covid is extending to the HPV vaccine, at least in the short term. So, what we've seen between 2019 and 2021 is that HPV vaccine uptake among teenagers actually has gone up each year. So, at least in the short term, the vaccine hesitancy associated with the Covid vaccine does not seem to have extended to the HPV vaccine. Dave Johnson: So, Doug, I'm going to shift gears just a little bit. I read recently, in Science, that China had overtaken the United States in terms of scientific publication and impact; and I'm wondering what you think about that, and what we need to do to retain our longstanding leadership in that role. Or does it really matter? Dr. Doug Lowy: If China's research, if their quality is outstanding-- I mean, there's nothing wrong with another country making important contributions to biomedical research. I don't see this, per se, as a competition. Perhaps, it's because I'm just looking at it through the lens of cancer research, and we think that cancer research is much too big to be done exclusively through support of NCI, exclusively in the United States, et cetera. So, to me, if other countries are doing high-quality research that can help people all over the world with regard to cancer- Pat Loehrer: -Let me ask you this, Doug, you've been at the NCI for 50 years. And I calculated that you've served under nine presidents, and of the NCI's 16 directors, you've served with 10 of them- Dr. Doug Lowy: Really ancient. Thank you. Pat Loehrer: -so, with all that, what do you think; one, about the importance of the NCI, and then also, we'll ask you a little bit about the reflections of the directors, and lessons learned from them, and maybe, some good stories. So, where do you think the NCI stands, and why is it important for the world, and for the country? Dr. Doug Lowy: What's really important is the funding from Congress. It is long-term and sustained. Cancer research can't be done in two or three years. It just takes a while to do really high-quality cancer research. And what really counts, from my perspective, is you can rely on the government to be strongly supporting cancer research through the NCI. In other words, private philanthropy is very important, but private philanthropy can decide, "Tomorrow we don't want to be doing what we have been doing." It's very much like pharmaceutical companies - they can decide that they're not going to be doing it. But it's almost impossible for us to say, "We are no longer going to support basic science research. Okay? We're not interested in investigator-initiated research," because, of course, we are. And that's the bedrock of development. We can't say, "We're no longer interested in doing clinical trials," because, of course, we are, because we can't make the progress that we need to make without clinical trials. We can't say, "We're not interested in doing implementation research," because it's one thing to have a new approval, it's something else to have it widely and equitably disseminated, and doing some kind of research with implementation. Science is critically important, and this applies for prevention, screening, diagnosis, treatment, survivorship, all of these areas that NCI supports, and will continue to support. The proportion may vary from one year to another, from one director to another, but all of those areas are going to continue to be supported. Dave Johnson: So, Doug, during your various tenures as the interim director, what program or programs are you most proud about? Dr. Doug Lowy: Instead of programs that I'm most proud of, I would say that working with NCI staff is what enables the achievement. The mission of the NCI is just incredible, and virtually everyone on the staff buys into the mission; which is, to help people live longer and healthier lives through research-related advances in cancer. That's what people do. And the first time when I was Acting Director, was the first Cancer Moonshot, so I was involved in that. But tremendous amount of credit needs to go to the Obama administration for wanting to do it, to the Congress for its strong bipartisan support for the initial Cancer Moonshot, and to my NCI colleagues, and then extramurally, for everybody who really got on board and tried to do things. So, this is very much a team effort, and it's not limited to NCI, you know, extramural colleagues are critically important to everything that we do. Pat Loehrer: Doug, you've alluded to the fact that you've served under so many different presidents and directors, and they all have different leadership styles. If you were gonna be a mentor on leadership, what advice would you give to the listeners as to what makes a good leader, and perhaps, what makes a not-so-good leader too? Dr. Doug Lowy: I think that there is a spectrum - there are some people who lead by intimidation, and some people who lead by example; and all of them can be effective leaders. My own view is that I like to lead by example because I really feel that that leads to very high morale. People who lead by intimidation may get a lot of work out of people, but it is nowhere near as satisfying as knowing that you are an extraordinarily, highly-valued member of a team and that the whole is greater than the sum of its parts. So, I think that having tremendous admiration and respect for the people that you work with, is absolutely number one, and number two, is listening to them. You don't always need to do what they advise, but people really thrive on being listened to, and everybody wants to make a difference. And so, help them to achieve that goal. When they look good, you'll look good. Dave Johnson: So, Doug, I'm attending on the general medical wards right now. Just got asked today by the medical students to give them some advice about the future of Oncology, and where did I think it was going. Before I go back and meet with them, I'd love to get your thoughts. Dr. Doug Lowy: Well, the future of oncology is extraordinarily bright. On the one hand, we've made tremendous progress. On the other hand, there are still 600,000 people dying every year in the United States from cancer, and worldwide, the problem is even greater. But what's going to happen in the future is, we will understand the causes of cancer better, and so, that will enable us to prevent more cancers. I think there's going to be an enormous increase in the opportunities for screening, and to reduce either the incidence of cancer or increase the outlook for people with cancer, because asymptomatic cancer will be diagnosed at a substantially earlier time point. And then when it comes to treatment, my view is, we've barely scratched the surface. With the opportunities for making drugs, immuno-oncology, and who knows what other areas lie in front of us, are almost limitless. The Biden administration has a goal for the reignited Cancer Moonshot of decreasing the mortality rate over the next 25 years by 50%. What I think we need to do is to decrease mortality over the next 25 years by even more than that, and in addition, to make progress against those cancers where progress thus far has been limited. Take pancreatic cancer as a specific example; 10 years ago, the RAS oncoproteins were thought to be undruggable targets. But last year, we had the first approval from the FDA of a RAS-specific inhibitor. The good news is, that can target about half of lung cancer that has mutant RAS. The bad news is, it targets very few people with pancreatic cancer who have mutant RAS. On the other hand, there now are G12D inhibitors where there's excellent preclinical data and hopefully, sometime next year, be starting clinical trials. G12D mutations account for about half of people with pancreatic cancer. If the success there mirrors the success that we've seen thus far with lung cancer, it means that we are potentially on the way to actually making a difference in outlook for people with pancreatic cancer. But I just see this as one of many opportunities as time goes forward. Pat Loehrer: You did, this week, something that no one has done, and that is, to turn the reins of the directorship of the Cancer Center, over to the first woman director, Monica Bertagnolli. What was in your letter that you left on the desk that you gave her? What kind of advice did you give her? Dr. Doug Lowy: My advice that I gave her was really, "How can I help you the best and the most?" Dave Johnson: That's awesome advice. No doubt about it. It's a really historical moment, and of course, we, who are members of ASCO, are particularly proud that Monica has taken the reins, as a former ASCO president. And Doug, we really appreciate you taking the time to spend with us. It's been incredibly interesting, and congratulations on an amazing career. Pat Loehrer: Absolutely. Dave Johnson: And also, thanks to our listeners for tuning in to Oncology, Etc. As you know, this is an ASCO Educational podcast, where Pat and I will talk about just about anything. If you have an idea for a topic or a guest you'd like us to interview, please by all means email us at: education@asco.org      Thank you for listening to the ASCO Education Podcast. To stay up to date with the latest episodes, please click, "subscribe". Let us know what you think by leaving a review. For more information, visit the Comprehensive Education Center, at: education.asco.org.  The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy, should not be construed as an ASCO endorsement.     

Vaccine development is a tremendous scientific breakthrough benefitting countless human lives. In Part 1 of this ASCO Oncology, Etc. Education Podcast episode, you will hear from the pioneering co-developer of the HPV vaccine Dr. Doug Lowy who serves as Principal Deputy Director of the National Cancer Institute , He speaks about how he got into the cancer field through the influence of his parents (4:49), the path that led him to focus on HPV (8:04), and his collaborative professional partnership with fellow HPV vaccine developer Dr. John Schiller (9:31). He also discusses his ongoing trial of one-dose administration, which promises to boost HPV vaccine uptake and reduce the burden of cervical cancer globally. If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at education@asco.org. TRANSCRIPT Pat Loehrer: Hi, I'm Pat Loehrer. I'm Director of the Center of Global Oncology and Health Equity at Indiana University. Dave Johnson: I'm Dave Johnson. I'm a Professor of Medicine at UT Southwestern Medical Center in Dallas, Texas. Pat Loehrer: And this is Oncology, Etc. Dave, what have you been reading lately? Dave Johnson: Well, you and I have talked about a couple of books, but I thought in light of our guest today, I would mention a book I actually read probably nearly 60 years ago called The Microbe Hunters by Paul de Kruif - very interesting book, written, if memory serves me correctly, in the '30s, about many of the early bacteriologists and physicians who were interested in microbes; Pasteur, for example, and others. And I don't remember all the details, but it certainly was one that was influential for my choice of Medicine as a career, much like Arrowsmith. It was a really impactful book. I doubt many of our listeners today would've read that book, but if one is interested in the history of Medicine, it's a really interesting book to read. Pat Loehrer: You said 60 years ago. Okay, when I was reading books back then, it was about Dick and Jane. Dave Johnson: It's my understanding that you're not past Dick and Jane yet. Pat Loehrer: Good, good point. Good point. Well, it's such an incredible honor today, we have Dr. Doug Lowy as our interviewee today. Doug is the Principal Deputy Director of the National Cancer Institute and Chief of the Intramural Laboratory and Cellular Oncology Program at the Center for Cancer Research. He has served as Acting Director more than any other person - he served as Acting Director between April of 2015 and October of 2017, between April of 2019 and October of 2019, and most recently, he served as an Acting Director until Monday of this week, October 3rd. I had a chance of seeing Doug, I think, about a year ago, a week after he took over, and this is great to have that bookend here. He has had this title of Principal Deputy Director since July of 2010 and he leads many of the NCI's key scientific initiatives. He graduated from Amherst College, I think in Art History, I may be wrong on that, received his medical degree from New York University School of Medicine, trained in Internal Medicine at Stanford, and did a Dermatology Residency at Yale. His focus has been on papillomavirus and the regulation of normal and neoplastic growth. The papillomavirus is in close collaboration with Dr. John Schiller with whom he's co-authored 150 papers over the last 25 years. In the 1980s, he studied the genetic organization of papillomaviruses and identified oncogenes that were encoded by the virus, and he's been integrally involved and instrumental in the development of the papillomavirus vaccine. His laboratory did work with the RAS gene family and other suppressor genes, and as you can guess, he's just one heck of a smart guy. For his body of work and together with Dr. Schiller, they received the Federal Employee of the Year Award in 2007 and the Partnership for Public Service Award, the Dorothy P. Landon American Association for Cancer Research Prize for Translational Research, the Albert B. Sabin Gold Medal in 2011. In 2007, he got the Medal of Honor for basic research from the American Cancer Society, and President Obama awarded him the National Medal of Technology and Innovation in 2014. And in 2017, he received the Lasker-DeBakey Clinical Medical Research Award, which is considered one of the most prestigious honors in biomedical research. He is listed in the Institute of Scientific Information as one of the most highly-cited authors in Microbiology, and obviously, he's a member of the National Academy of Science and the National Academy of Medicine. Although these are notable honors, I'm told that none of them match the opportunity to speak with Dave and I today, and we really thank you so much, Dr. Lowy, for joining us. Thank you. Dr. Doug Lowy: Pat, I am speechless. Pat Loehrer: I so wish that Dave Johnson was, but could you tell us a little bit about your upbringing and your early life? Dr. Doug Lowy: Sure. I grew up in The Bronx, in New York City. I'm the younger of two boys. My brother is two and a half years older than I am. Both of my parents were general practitioners. My parents were both Americans, but my father had a classic sophomore slump when he was an undergraduate and was unable to get into a medical school in the United States. And so, he actually went to medical school in Austria, in the University of Vienna, and needed to learn German in order to go to medical school. But my parents were both very successful private practitioners. They had separate practices but practiced in the same office, and I learned about medicine, in large part, through them. They would go to lectures, and from the time I was probably nine or 10 years old, they would be telling me about cancer, and I became interested in that area. And then, when I was 16, my mother developed a deep melanoma on her leg, and so, cancer literally came home. And luckily, she had very good surgical treatment and lived for almost another 40 years - she lived until she was 80 and actually died of metastatic stomach cancer. But I got involved in thinking about cancer really through my parents. They talked with me about the role of tobacco in the development of lung cancer, and I heard about the Hammond and Horn report from the mid-1950s when it came out. Pat Loehrer: That was when Dave was reading the Microbe Hunters. Dr. Doug Lowy: I was reading it at about the same time. I must say that, although I found it very interesting, it didn't really speak to me, and now that's what I need to go and do. Although, in retrospect, that's what I've ended up going and doing. Pat Loehrer: Was it because of your mother that you had an interest in dermatology? How did you swing into there? Because we think of you mostly as a translational researcher. Dr. Doug Lowy: The dermatology was really when I was at NYU. I worked in the laboratory of Jan Vilcek, who had recently come from Czechoslovakia to NYU, and in his lab was Alvin Friedman-Kien, who was a dermatologist. And Alvin subsequently was among the first people to identify the AIDS epidemic through the Kaposi sarcoma. But Alvin talked with me about dermatology, and potentially, this might be an interesting field for me to go into. And then, when I went to Stanford, I did Internal Medicine for internship and a year of Medicine, and I did a rotation in Dermatology. And I was very impressed that the people who smiled the most were the dermatologists. And they had time also to think about what was going on with patients. And since I was at Stanford, it was a tertiary care facility and so we were taking care of people who were terribly sick, largely people with lymphoma and other types of cancer. And I thought that I might be better suited to taking care of people who were less sick than that. Dave Johnson: Is that where your interest in Papillomavirus started? Dr. Doug Lowy: Well, that was indirect. I first went into dermatology and then said, "Well, I want to be doing research. What can I do in research that might be connected both with dermatology as well as with cancer?" And the closest that I was able to come was Papillomaviruses. And when I started working on them, they were not yet clearly associated with cancer the way they are today. It was known that they were associated with an uncommon condition called Epidermodysplasia Verruciformis or EV and this is a condition where people have widespread HPV infection. And on sun-exposed areas, a subset of them develop skin cancer, but it's distinctly uncommon. The real interest, if you will, came from the identification of HPV infection and cervical cancer, which is one of the more common cancers, especially on a worldwide basis. And that was really the link with cancer. Pat Loehrer: You had an incredibly long-term collaboration with John Schiller, and as I mentioned, you published more than Dave and I have written letters to our wives with this man. Tell us a little bit about that relationship, that friendship, and that professional partnership. Dr. Doug Lowy: John, actually, he was at the University of Washington in Seattle doing his PhD, and it was so long ago that he sent me a letter, and I had been doing research on retroviruses. He sent me a proposal that he was doing his PhD in bacterial genetics, but he wanted to learn about mammalian viruses and so was writing to me about doing work with retroviruses. I wrote back to him and said, "That's very interesting, but I had just started working on papillomaviruses." And I thought the room for development and learning more was even greater there than with mouse retroviruses, which is what I was working on and what he was proposing to do some post-doctoral research on. Of course, he had never heard of papillomaviruses, so he had to look them up. But he developed a project with papillomaviruses and was able to get an NIH award to come as a postdoctoral fellow to work in my lab, and he actually did the research that he proposed, and it led to our improved understanding of the genetic organization of papillomaviruses. But then, it was clear that John and I got along very well, and it looked like both of us might be able to work together. So, he ended up getting tenure after he had been at NIH for about 10 years. And it's just been an amazing collaboration for me because John knows a lot of things that I don't know, and he thinks that I know some things that he doesn't know. And working together has been terrific, really, because when one of us doesn't want to do anything about something, the other one tends to step in. And so, it's been an amazing partnership that we have had for this time. Dave Johnson: This is really important. One of the reasons we agreed to do this podcast is to provide insight to up-and-coming faculty and fellows about mentoring and partnerships. What is the most important aspect of your partnership with Dr. Schiller? Dr. Doug Lowy: I think treating him as an equal colleague from day one, that probably is important. And then, since I was senior and he was junior, trying to make sure that he got credit when discoveries were made because the default, otherwise, was going to be that it was Doug Lowy who was doing things, whereas it was very clear that John was a key part of this collaboration. Dave Johnson: Now that your relationship is a long-lasting and mature one, how do you make those decisions now? Dr. Doug Lowy: Well, we've just worked together for a long time, and we enjoy talking, and actually, over the last few years, we are collaborating less rather than more. We're still very close colleagues, and we're in the same lab. But since I've been Deputy Director, especially during the last seven and a half years, I've been Acting Director for about three and a half out of the last seven and a half years, and there just isn't enough time to devote to the lab. And it would've been inappropriate for me to have been considered a co-principal investigator with John, who has gone off and done a lot of amazing research, more or less independent of me. Like everything else in this world, it develops, it continues to evolve, but we still are very close colleagues. As Pat was mentioning, this is my first week in several months not being Acting Director, and yesterday, John and I simply reveled in the opportunity to talk informally for 30 minutes without having to look at my watch because I needed to go someplace else. Dave Johnson: I'm glad you've reviewed that. I think a lot of junior faculty and fellows think that being in a leadership position is a cush job, and I'd tell them that it defies the laws of Physics because all poop flows uphill in this setting, and you have to deal with it. Pat Loehrer: I do want to spend some time talking about the NCI and your role there, but talk a little bit about how you have seen and where you envision that vaccines, particularly, HPV and maybe hepatitis vaccine - where you see it's been, and where it's going, and the impact that this potentially has on cancer worldwide? Dr. Doug Lowy: Well, one of the areas that John and I are continuing to work on closely is more research on the HPV vaccines. We noticed, quite a number of years ago, that the HPV vaccine performance was quite different from that of other so-called subunit vaccines. So, this is not an attenuated live vaccine, but instead is a subunit - it's just made up of one protein of the papillomavirus, the protein that gives rise to the outer shell of the virus. And what we noticed in a clinical trial that we were doing with colleagues in the intramural program, but who are medical epidemiologists - they are the leaders of the research, and what was happening was that although everyone was supposed to get three doses, there were some young women who were getting either two doses or one dose, in the trial, and this is in Costa Rica, where historically, cervical cancer has been the number one cancer of women. And it turned out that there was no difference in level of protection whether the women got one dose, two doses, or three doses. And even more surprising was that the antibody levels over the first few years were remarkably stable. And this led John and me to wonder whether it might be possible to get away with just a single vaccine dose. So, a lot of the research that we have been doing with our colleagues over the last few years is to develop stronger evidence that one dose of the vaccine would be sufficient to confer strong protection that's long-lasting. We've now carried out the studies in Costa Rica, with the initial trial to more than 10 years, and the antibody levels continue to be very stable, and the protection does not seem to have waned. Because this was not a pre-specified outcome, it's not enough to change standard of care. So, we and our colleagues are conducting a non-inferiority efficacy trial that is comparing two doses versus one dose of two different FDA-approved vaccines. One, GARDASIL 9, which is the HPV vaccine that's available for sale in the United States. But also Cervarix, which is made by GlaxoSmithKline, it's approved by the FDA, but it's no longer sold in the United States. And we anticipate that the results will read out in another couple of years. And if the results show that one dose and two doses are pretty comparable, we're expecting that this will lead to a worldwide change in recommendations for the HPV vaccine. So, whether you are in a high-income country or a low or middle-income country, that one dose is what will end up being recommended. Pat Loehrer: They could almost completely eradicate this disease, the most common cancer around the world. It's huge. Dr. Doug Lowy: So, Pat, the problem is that although the vaccine was approved 15 years ago, only about 10% of eligible young women in low and middle-income countries have actually been vaccinated up to now. And we think that the logistics and the cost of one dose could really be transformative, especially for those young women. It also would save the United States a great deal of money because needing only one dose would be far less expensive, and the government actually pays for about half of the HPV vaccine that is delivered to teenagers through the Vaccines for Children program.   Dave Johnson: Well, this concludes part one of our interview with Dr. Doug Lowy, Principal Deputy Director of the National Cancer Institute and Chief of the Intramural Laboratory of Cellular Oncology in the Center for Cancer Research. In the second part of this episode, Dr. Lowy will give his insight to vaccine hesitancy in the COVID era and the evolution of accomplishments over the past 50 years working at the National Cancer Institute. We want to thank all of our listeners for tuning in to Oncology, Etc. an ASCO Educational podcast, where we will talk about just about anything and everything. So, if you have an idea for a topic or a guest you would like for us to interview on the show, please email us at: education@asco.org.   Thank you for listening to the ASCO Education podcast. To stay up to date with the latest episodes, please click, Subscribe. Let us know what you think by leaving a review. For more information, visit the Comprehensive Education Center, at: education.asco.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy, should not be construed as an ASCO endorsement.    

In August, President Biden signed the Inflation Reduction Act into law. The IRA allocates around $370 billion over ten years to invest in renewable energy, make EVs more affordable, address climate inequities, reduce greenhouse gas emissions and help mitigate the climate crisis.  But like any law, the way the money is doled out matters, and the law's implementation will ultimately determine its success. Some of the IRA money moves through state governments, including some that are outright hostile to the law. Consumers will have access to a suite of rebates and credits designed to electrify their lives, if they can get the necessary support to take advantage of them. How can government agencies, companies, investors and individuals take the law from words on a page to real functioning programs?  Guests:  Carla Frisch, Principal Deputy Director, Office of Policy for the U.S. Department of Energy  Ryan Panchadsaram, Advisor to the Chairman at Kleiner Perkins  Erwin Chemerinsky, Dean, Berkeley Law Dan Bowerson, Senior Director, Energy & Environment, Alliance for Automotive Innovation Learn more about your ad choices. Visit megaphone.fm/adchoices

In August, President Biden signed the Inflation Reduction Act into law. The IRA allocates around $370 billion over ten years to invest in renewable energy, make EVs more affordable, address climate inequities, reduce greenhouse gas emissions and help mitigate the climate crisis.  But like any law, the way the money is doled out matters, and the law's implementation will ultimately determine its success. Some of the IRA money moves through state governments, including some that are outright hostile to the law. Consumers will have access to a suite of rebates and credits designed to electrify their lives, if they can get the necessary support to take advantage of them. How can government agencies, companies, investors and individuals take the law from words on a page to real functioning programs?  Guests:  Carla Frisch, Principal Deputy Director, Office of Policy for the U.S. Department of Energy  Ryan Panchadsaram, Advisor to the Chairman at Kleiner Perkins  Erwin Chemerinsky, Dean, Berkeley Law Dan Bowerson, Senior Director, Energy & Environment, Alliance for Automotive Innovation Learn more about your ad choices. Visit megaphone.fm/adchoices

0:00 - Dan & Amy take a look at the latest in the Mar-a-Lago raid and the left's new political hit job against Trump in New York    7:47 - Dan & Amy react to the class-action lawsuit against DeSantis over Martha's Vineyard    29:28 - Dan & Amy give an update on Stephen DeFilippis harassers John Ruder & Robert Shumacker   50:12 - Senior Fellow with the Mises Institute who served as the Principal Deputy Director of the Office of Financial Research in the U.S. Treasury Department and former President and CEO, Federal Home Loan Bank of Chicago, Alex Pollock: The Fed's Tough Year   01:01:31 - National political reporter, Salena Zito, shares the difficulties and realities of covering John Fetterman. Check out Salena's always timely book  The Great Revolt: Inside the Populist Coalition Reshaping American Politics   01:18:52 - Defending the Willie Wilsonization of politics   01:36:18 - Hall of Fame Chicago Bears Linebacker, Brian Urlacher, shares what he learned from his recent trip to the nation's border    01:53:31 - Karol Markowicz, columnist for the New York Post: Continuing COVID craziness shows it was never about the science. Karol is a great follow on twitter @karolSee omnystudio.com/listener for privacy information.

Sue is currently the Director at CACI International which provides the unique expertise and distinctive technology that address customers' greatest enterprise and mission challenges. She was the fifth Principal Deputy Director of National Intelligence at the Office of the Director of National Intelligence (DNI) from August 2017 to August 2019. As PDDNI, Sue was a key advisor to the President and National Security Council and led the 17-member Intelligence Community. With more than three decades of experience in the IC, Sue has served in a variety of leadership roles spanning numerous intelligence organizations and disciplines. Prior to the DNI, Sue served as the Deputy Director of the National Geospatial-Intelligence Agency from 2015 to 2017, helping the director lead the agency and manage the National System of Geospatial Intelligence. Before joining the NGA, she served for 27 years at the Central Intelligence Agency, rising to senior executive positions in each of the Agency's four directorates: operations, analysis, science and technology, and support. In 1998, she designed and drove the formation of In-Q-Tel, a private, non-profit company whose primary purpose is to deliver innovative technology solutions for the agency and the IC. She is the recipient of numerous government and industry awards, including the Distinguished Intelligence Medal and the Distinguished Presidential Rank Award. Sue earned a Bachelor of Science from Duke University. A trusted authority on strategy, innovation and leadership, Sue is currently a consultant on global risk, technology, cyber and space issues and a member of the Board at Pallas Advisors, a Washington D.C.-based consultancy.  Summary:In this week's episode of Building the Base, Hondo and Lauren join Sue Gordon, Director at CACI International and former Principal Deputy Director of National Intelligence, to discuss the future of the defense industrial network. In the first part of the podcast, Sue touches on inefficiencies in the defense acquisition system and the procedural and cultural barriers one must overcome when innovating. One of the most promising avenues Sue highlighted was increased collaboration with the private sector, an area which has seen increased activity in part spurred on by the urgency of the Ukraine crisis.  Hondo, Lauren, and Sue go on to discuss a variety of topics, including:Public/private collaboration in the intelligence communityLeadershipWork/life balance when in high pressure jobsHow the national security sector needs to improve its talent acquisition practicesMentorship

This week, we take our listeners back to November 18, 2021, when we were just starting Chatter, to bring back one of our very special episodes.David Priess's guest that day was former Principal Deputy Director of National Intelligence (PDDNI) and longtime intelligence officer Sue Gordon, who shared stories about her experiences in team sports, lessons on leadership, her role in creating the CIA's non-profit venture capital firm (In-Q-Tel), what it was like interviewing with Donald Trump for the PDDNI job, and more.Enjoy this archive episode, and we will return next week with an all new conversation.Chatter is a production of Lawfare and Goat Rodeo. This episode was produced and edited by Cara Shillenn of Goat Rodeo. Podcast theme by David Priess, featuring music created using Groovepad. See acast.com/privacy for privacy and opt-out information. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

0:00 - Aaliyah Ivory (CCW holder) on being shot 6 times on Xway (I-57 & Vollmer) 8:37 - Dan & Amy check in on JB Pritzker as he travels to Florida 27:28 - Barstool:  Ranking The Chicago Highways 45:28 - Dan & Amy remark on the good samaritan who saved lives at Indiana mall 01:01:05 - Author of  The Coming Collapse of China  and The Great U.S.-China Tech War, Gordon Chang: China's Economy Is Now In Free Fall. Gordon has contributed to a new book The CCP is at War with America and is a must follow on twitter @GordonGChang 01:17:03 - President of Wirepoints, Ted Dabrowski, does a stop, look and listen as Illinois state elections near in November. Check out Ted's latest at wirepoints.org 01:33:38 - Alex Pollock, senior Fellow with the Mises Institute, served as the Principal Deputy Director of the Office of Financial Research in the U.S. Treasury Department, former President and CEO, Federal Home Loan Bank of Chicago, explains why economics is not a science. For more from Alex on the “tyranny of the experts” check out his book Finance and Philosophy—Why We're Always Surprised 01:50:01 - Rev. Terrell Scott, pastor of Passion-Life Church in McDonough, Georgia, shares his journey from crime boss to ministry. For more on Passion-Life Church visit passion-life.org See omnystudio.com/listener for privacy information.

You only represent 2% of the population, but you are the most targeted religious group in the country with over 60% of the hate crimes committed against your constituency. You can't sit on the sidelines. You must be engaged with the right people, process, technology, and partners if you hope to provide protection in the “most complex, dynamic, risk environment ever”. We engaged the Principal Deputy Director and COO, Patrick Daly of the Secure Community Network (SCN) to help us understand what the threat is and how to mitigate and respond to it. SCN is The Secure Community Network (SCN) is the official safety and security organization of the Jewish community in North America. It provides Intelligence and Information Sharing, Facility Assessments, Physical Security Solution Support, Training, Exercise and Education, a partnership with Law Enforcement, and Incident Response and Crisis Management. Patrick is responsible for strategic planning, organizational management and Board engagement of the official homeland security initiative for the American Jewish Community. He oversees coordination and engagement between federal law enforcement and over 200 organizations. SCN is recognized by U.S. Department of Homeland Security as a national model. We have a great conversation with a resolute and passionate advocate for the security and safety of this country and his stakeholders.

CSIS Senior Associate Nina Easton spoke with the Principal Deputy Director of National Intelligence Dr. Stacey Dixon for a discussion on the greatest intelligence challenges facing the world today. In addition, the PDDNI discussed her remarkable career path, how the IC is being positioned for the future, as well as how they are promoting competitiveness and innovation.

If you're not a Subscriber+Member, you can upgrade your access at the cipher brief website and one more note before we get to today's report – The Cipher Brief is hosting a live web briefing next Wednesday, April 13th with Principal Deputy Director for National Intelligence Dr. Stacey Dixon, former Assistant Secretary for Intelligence and Research The Hon. Ellen McCarthy and former Senior CIA Officer Teresa Smetzer on Disinformation and How Spies Can Help Find Truth.  Brad, you and I know that U.S. adversaries are actively driving campaigns that take a nugget of truth to build false and divisive narratives around and it's impacting national security.  We'll be talking in this brief about how can lessons from the Intelligence Community can help guide a new path for truth.

Alex J. Pollock is a Senior Fellow with the Mises Institute, previously the Distinguished Senior Fellow at the R. Street Institute, and the former Principal Deputy Director of the U.S. Department of Treasury's Office of Financial Research. He is also the former President and CEO of the Federal Home Loan Bank of Chicago. Holding advanced degrees from the University of Chicago, and Princeton University, he is the author of the legendary book, Finance and Philosophy: Why We're Always Surprised.

On this week's episode of Chatter, David Priess has a conversation with former Principal Deputy Director of National Intelligence (PDDNI) and longtime intelligence officer Sue Gordon. Sue shares stories about her experiences in team sports, her lessons on leadership, her role in creating the CIA's non-profit venture capital firm (In-Q-Tel), her interview with Donald Trump for the PDDNI job, and more. Chatter is a production of Lawfare and Goat Rodeo. This episode was produced and edited by Cara Shillenn of Goat Rodeo with engineering assistance from Ian Enright.Podcast theme by David Priess, featuring music created using Groovepad. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

Acting Assistant Attorney General for the Criminal Division Brian Rabbitt speaks with Matt Lloyd, Principal Deputy Director of Public Affairs, about how the Department of Justice's Criminal Division is working to combat the opioid epidemic.